Change Path »

Vertex Pharmaceuticals Incorporated shares owned by Change Path

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Change Path from 13F filings

Historical chart of Change Path investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Change Path consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Change Path

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 4.2k 468.73
2024-03-31 $2.5M 5.5k 454.55
2023-06-30 $1.1M 2.6k 400.00
2023-03-31 $936k 3.0k 315.20
2022-12-31 $809k 2.8k 288.79
2022-09-30 $899k 3.1k 289.53
2022-06-30 $228k 808 282.18
2022-03-31 $219k 839 261.03

More positions owned by Change Path

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Apple (AAPL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Change Path

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Wellington Management Company
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services

View all funds holding Vertex Pharmaceuticals Incorporated